cAMP phosphodiesterase type 4 (PDE4) inhibitors, by blocking cAMP degradation, activate cAMP-mediated signaling and induce apoptosis in CLL cells. The gene discussed is PDE4A; the disease is B-cell chronic lymphocytic leukemia.